BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2019

Mar 20, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2019-03-15

Reporting Person: BIENAIME JEAN JACQUES (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-03-15	Common Stock	F	28143	$94.53	Disposed	300558	Direct
2019-03-15	Common Stock	A	34780	—	Acquired	335338	Direct
2019-03-15	Common Stock	M	4000	$14.39	Acquired	339338	Direct
2019-03-15	Common Stock	S	4000	$94.4	Disposed	335338	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-03-15	Stock Option (Right to buy Common Stock)	$94.53	A	87080	Acquired	2029-03-14	Common Stock (87080)	Direct
2019-03-15	Stock Option (Right to buy Common Stock)	$14.39	M	4000	Disposed	2019-05-11	Common Stock (4000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	181341	Indirect

Footnotes

F1: Restricted stock units granted on March 15, 2019. Price not applicable.

F2: Trade made pursuant to a 10b5-1 plan executed on September 10, 2018.

F3: Option grant vests 12/48th on March 15, 2020 and 1/48th on the 15th day of each month thereafter.

F4: Reflects the number of options outstanding after the transactions from this specific stock option grant.